Legend Biotech (LEGN) Capital Expenditures (QoQ) (2020 - 2025)
Legend Biotech (LEGN) Capital Expenditures (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 45.74% |
| Jun 30, 2025 | -360.74% |
| Mar 31, 2025 | -107.75% |
| Dec 31, 2024 | 1,350.94% |
| Sep 30, 2024 | 39.60% |
| Jun 30, 2024 | 45.23% |
| Mar 31, 2024 | -117.43% |
| Dec 31, 2023 | 766.23% |
| Sep 30, 2023 | 11.68% |
| Jun 30, 2023 | -42.44% |
| Mar 31, 2023 | 79.58% |
| Dec 31, 2022 | -711.75% |
| Sep 30, 2022 | 78.59% |
| Jun 30, 2022 | -5,034.43% |
| Mar 31, 2022 | 100.58% |
| Dec 31, 2021 | -267.54% |
| Sep 30, 2021 | 60.30% |
| Jun 30, 2021 | -289,060.00% |
| Mar 31, 2021 | 99.96% |
| Dec 31, 2020 | -270.04% |